NO178698C - Analogifremgangsmåte for fremstilling av terapeutisk aktive glycerolderivater - Google Patents

Analogifremgangsmåte for fremstilling av terapeutisk aktive glycerolderivater

Info

Publication number
NO178698C
NO178698C NO905377A NO905377A NO178698C NO 178698 C NO178698 C NO 178698C NO 905377 A NO905377 A NO 905377A NO 905377 A NO905377 A NO 905377A NO 178698 C NO178698 C NO 178698C
Authority
NO
Norway
Prior art keywords
preparation
therapeutically active
glycerol derivatives
analogous process
active glycerol
Prior art date
Application number
NO905377A
Other languages
English (en)
Norwegian (no)
Other versions
NO905377D0 (no
NO905377L (no
NO178698B (no
Inventor
Pierre Braquet
Colette Broquet
Paola Principe-Nicolas
Benedicte Vandamme
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898929074A external-priority patent/GB8929074D0/en
Priority claimed from GB898929075A external-priority patent/GB8929075D0/en
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of NO905377D0 publication Critical patent/NO905377D0/no
Publication of NO905377L publication Critical patent/NO905377L/no
Publication of NO178698B publication Critical patent/NO178698B/no
Publication of NO178698C publication Critical patent/NO178698C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • C07C215/10Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with one amino group and at least two hydroxy groups bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C07D213/20Quaternary compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/10Phosphatides, e.g. lecithin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
  • Hydrogenated Pyridines (AREA)
  • Furan Compounds (AREA)
  • Steroid Compounds (AREA)
NO905377A 1989-12-22 1990-12-12 Analogifremgangsmåte for fremstilling av terapeutisk aktive glycerolderivater NO178698C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898929074A GB8929074D0 (en) 1989-12-22 1989-12-22 Glycerol derivatives
GB898929075A GB8929075D0 (en) 1989-12-22 1989-12-22 Glycerol derivatives

Publications (4)

Publication Number Publication Date
NO905377D0 NO905377D0 (no) 1990-12-12
NO905377L NO905377L (no) 1991-06-24
NO178698B NO178698B (no) 1996-02-05
NO178698C true NO178698C (no) 1996-05-15

Family

ID=26296423

Family Applications (1)

Application Number Title Priority Date Filing Date
NO905377A NO178698C (no) 1989-12-22 1990-12-12 Analogifremgangsmåte for fremstilling av terapeutisk aktive glycerolderivater

Country Status (26)

Country Link
US (1) US5116992A (pt)
JP (1) JP2648730B2 (pt)
KR (1) KR950012533B1 (pt)
AR (1) AR247875A1 (pt)
AT (1) AT398423B (pt)
AU (1) AU635991B2 (pt)
BE (1) BE1004091A3 (pt)
CA (1) CA2032254C (pt)
CH (1) CH681225A5 (pt)
DE (1) DE4041449A1 (pt)
DK (1) DK171021B1 (pt)
ES (1) ES2027550A6 (pt)
FI (1) FI906203A (pt)
FR (2) FR2656221B1 (pt)
GR (1) GR1000688B (pt)
HK (1) HK117993A (pt)
IE (1) IE65821B1 (pt)
IT (1) IT1243413B (pt)
LU (1) LU87860A1 (pt)
NL (1) NL9002742A (pt)
NO (1) NO178698C (pt)
NZ (1) NZ236483A (pt)
OA (1) OA09336A (pt)
PT (1) PT96322B (pt)
SE (1) SE501393C2 (pt)
TN (1) TNSN90153A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8928580D0 (en) * 1989-12-19 1990-02-21 Scras 3-(n-methyl-n-alkylamino)-methoxymethyl-propanol phosphocholine derivatives
US5206027A (en) * 1990-09-13 1993-04-27 Fuji Photo Film Co., Ltd. Amphipathic compound and liposome comprising the same
DE69535758D1 (de) * 1994-08-29 2008-07-03 Univ Wake Forest Lipid-analoge zur behandlung von viralen infektionen
US7135584B2 (en) * 1995-08-07 2006-11-14 Wake Forest University Lipid analogs for treating viral infections
US5707978A (en) * 1994-11-22 1998-01-13 Clarion Pharmaceuticals Inc. Heteroaryl-substituted deoxy glycero-phosphoethanolamines
US5665714A (en) * 1995-12-07 1997-09-09 Clarion Pharmaceuticals Inc. N-substituted glycerophosphoethanolamines
US5730157A (en) * 1995-12-07 1998-03-24 Clarion Pharmaceuticals Inc. Method for treating viral infection
US5703062A (en) * 1995-12-07 1997-12-30 Clarion Pharmaceuticals Inc. N-het-substituted glycerophosphoethanolamines
US5827836A (en) * 1996-11-15 1998-10-27 Clarion Pharmaceuticals Inc. Retinoid glycerol phospholipid conjugates
US5891881A (en) * 1997-11-21 1999-04-06 Clarion Pharmaceuticals Inc. Aminoheterocycle-substituted glycerols
US20050187192A1 (en) * 2004-02-20 2005-08-25 Kucera Pharmaceutical Company Phospholipids for the treatment of infection by togaviruses, herpes viruses and coronaviruses
PL2574341T3 (pl) 2004-03-29 2017-09-29 University Of South Florida Efektywne leczenie guzów i raka fosforanem tricyrybiny

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2820893C2 (de) * 1978-05-12 1986-02-20 A. Nattermann & Cie GmbH, 5000 Köln Strukturanaloga von natürlichen Phospholipiden und Verfahren zur Herstellung dieser Verbindungen
US4562179A (en) * 1982-04-19 1985-12-31 Fujisawa Pharmaceutical Co., Ltd. Phospholipid derivatives, and pharmaceutical composition of the same
DE3323871A1 (de) * 1983-07-02 1985-01-03 A. Nattermann & Cie GmbH, 5000 Köln Neue 1-o-alkyl-3-amino-propan-1,2-diol-2-o-phospholipide, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
US4863941A (en) * 1985-06-18 1989-09-05 Hoffmann-La Roche Inc. Glycerol derivatives

Also Published As

Publication number Publication date
AR247875A1 (es) 1995-04-28
IE904618A1 (en) 1991-07-17
NZ236483A (en) 1993-02-25
SE9003973D0 (sv) 1990-12-12
KR950012533B1 (ko) 1995-10-18
DK304090D0 (da) 1990-12-21
AU635991B2 (en) 1993-04-08
GR900100847A (en) 1992-05-12
IT9022439A0 (it) 1990-12-19
CH681225A5 (pt) 1993-02-15
BE1004091A3 (fr) 1992-09-22
IE65821B1 (en) 1995-11-15
FR2656308A1 (fr) 1991-06-28
PT96322B (pt) 1998-06-30
JP2648730B2 (ja) 1997-09-03
FR2656221A1 (fr) 1991-06-28
JPH0616605A (ja) 1994-01-25
IT1243413B (it) 1994-06-10
FR2656221B1 (fr) 1992-09-18
HK117993A (en) 1993-11-12
NL9002742A (nl) 1991-07-16
NO905377D0 (no) 1990-12-12
DK304090A (da) 1991-06-23
IT9022439A1 (it) 1992-06-19
FR2656308B1 (fr) 1994-04-01
SE501393C2 (sv) 1995-02-06
DE4041449A1 (de) 1991-06-27
ES2027550A6 (es) 1992-06-01
PT96322A (pt) 1991-09-30
NO905377L (no) 1991-06-24
NO178698B (no) 1996-02-05
LU87860A1 (fr) 1991-05-07
AU6837990A (en) 1991-07-11
SE9003973L (sv) 1991-06-23
FI906203A (fi) 1991-06-23
GR1000688B (el) 1992-10-08
OA09336A (fr) 1992-09-15
FI906203A0 (fi) 1990-12-17
ATA260590A (de) 1994-04-15
AT398423B (de) 1994-12-27
CA2032254A1 (en) 1991-06-23
CA2032254C (en) 1996-12-10
DK171021B1 (da) 1996-04-22
KR910011760A (ko) 1991-08-07
TNSN90153A1 (fr) 1991-03-05
US5116992A (en) 1992-05-26

Similar Documents

Publication Publication Date Title
FI96861C (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen indolyylipyrrolijohdannaisten valmistamiseksi
NO179584C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-acylaminotiazoler
NO176319C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive furanderivater
NO175478C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive diazepin-derivater
NO176759C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater
NO177387C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive imidazo-kondenserte, 6-leddede, heterocykliske forbindelser
NO174467C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater
NO175978C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive bis-aza-bicykliske forbindelser
NO178619C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive di-t-butylfenoler
NO178068C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive tiazolidindionderivater
NO176275C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridazinonderivater
NO178543C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive benzopyranderivater
NO176713C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-aminopyridinderivater
NO175528C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive fenylacetamid-derivater
NO173334C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive alkylaminoalkylenderivater 2H-1-benzopyraner
NO174959C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive N-aminobutyl-N-fenyl-arylamidderivater
FI93444B (fi) Menetelmä terapeuttisesti aktiivisten dihydropyridiinijohdannaisten valmistamiseksi
NO178698C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive glycerolderivater
NO173784C (no) Anaslogifremgangsmaate for fremstilling av terapeutisk aktive tieno-tri-azolo-diazepinderivater
NO174391C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater
NO176100C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive oksodihydropyridyl- og oksodihydropyridazinylkromanderivater
NO174422C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater
NO174203C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive
NO176099C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-(2-okso-3-pyridyl)-kromanderivater
NO174053C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive R(-) 3-kinuklidinol-derivater